Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France

• Main Authors: Matthieu Lehmann (Author), Elisangela Arbo (Author), Jean-Luc Pouly (Author), Paul Barrière (Author), Lauren Amy Boland (Author), Samuel George Bean (Author), Julian Jenkins (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: The study assessed cost-effectiveness of follitropin alfa biosimilar versus the originator in terms of cost per cumulative live-birth (CLB) for the French healthcare system based on real-world evidence. Follitropin alfa biosimilars have been shown to have comparable clinical outcomes to t...